ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Decoding the mechanism of Eleutheroside E in treating osteoporosis via network pharmacological analysis and molecular docking of osteoclast-related genes and gut microbiota

Zhou, Tianyu; Zhou, Yilin; Ge, Dongdong; Xie, Youhong; Wang, Jiangyan; Tang, Lin; Dong, Qunwei*; Sun, Ping*广东药学院; 1
Frontiers in Endocrinology2023-11-7DOI: 10.3389/fendo.2023.1257298
11阅读
引用收藏
分享

摘要

ObjectiveEleutheroside E (EE) is an anti-inflammatory natural compound derived from the edible medicinal herb Acanthopanax senticosus. This study aims to investigate the underlying mechanism of the anti-osteoporosis action of EE through network pharmacology, molecular docking and gut microbiota.Materials and methodsNetwork pharmacology was used to explore the potential core targets and main pathways mediated by EE in osteoporosis (OP) treatment. Molecular docking was exploited to investigate the interactions between the active anti-OP compounds in EE and the potential downstream targets. Following the multi-approach bioinformatics analysis, ovariectomy (OVX) model was also established to investigate the in vivo anti-OP effects of EE.ResultsThe top 10 core targets in PPI network were TP53, AKT1, JUN, CTNNB1, STAT3, HIF1A, EP300, CREB1, IL1B and ESR1. Molecular docking results that the binding energy of target proteins and the active compounds was approximately between -5.0 and -7.0 kcal/mol, which EE has the lowest docking binding energy with HIF1A. Enrichment analysis of GO and KEGG pathways of target proteins indicated that EE treatment could potentially alter numerous biological processes and cellular pathways. In vivo experiments demonstrated the protective effect of EE treatment against accelerated bone loss, where reduced serum levels of TRAP, CTX, TNF-alpha, LPS, and IL-6 and increased bone volume and serum levels of P1NP were observed in EE-treated mice. In addition, changes in gut microbiota were spotted by 16S rRNA gene sequencing, showing that EE treatment increased the relative abundance of Lactobacillus and decreased the relative abundance of Clostridiaceae.ConclusionIn summary, these findings suggested that the characteristics of multi-target and multi-pathway of EE against OP. In vivo, EE prevents the onset of OP by regulating gut microbiota and inflammatory response and is therefore a potential OP drug.

学科与关键词

关键词
Eleutheroside E (EE)postmenopausal osteoporosis (PMO)network pharmacologymolecular dockinggut microbiota
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2023-11-07
卷期
第 14 卷
页码
1257298
DOI
10.3389/fendo.2023.1257298
成果收录
SCIE
资助标注
National Science Foundation for Young Scholars, China [81603641]; Science and Technology Planning Project of Yunfu, Guangdong Province, China [2020A090402]

作者

  • Z

    Zhou, Tianyu (第一作者)

    1 · guangdong pharmaceut univ

  • Z

    Zhou, Yilin

    1 · guangdong pharmaceut univ

查看全部 8 位作者收起作者
  • G

    Ge, Dongdong

    1 · guangdong pharmaceut univ

  • X

    Xie, Youhong

    1 · guangdong pharmaceut univ

  • W

    Wang, Jiangyan

    1 · guangdong pharmaceut univ

  • T

    Tang, Lin

    1 · guangdong pharmaceut univ

  • D

    Dong, Qunwei (通讯)

    1 · guangdong pharmaceut univ

  • S

    Sun, Ping (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417